Clinical Trial Update: Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

View source ↗

Summary

A real-world study of Xeligekimab for moderate to severe plaque psoriasis is planned and not yet recruiting, sponsored by Chongqing Genrix Biopharmaceutical Co.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Psoriasis
• Nail Psoriasis
• Palmoplantar Psoriasis
• Plaque Psoriasis
• Psoriatic Arthritis
• Scalp Psoriasis

Drugs mentioned

• Xeligekimab

Snippet

Sponsor: Chongqing Genrix Biopharmaceutical Co., Ltd | Conditions: Plaque Psoriasis, Psoriatic Arthritis | Status: NOT_YET_RECRUITING